{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,24]],"date-time":"2026-01-24T06:49:41Z","timestamp":1769237381586,"version":"3.49.0"},"reference-count":0,"publisher":"Bentham Science Publishers Ltd.","issue":"16","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CPD"],"published-print":{"date-parts":[[2018,8,29]]},"abstract":"<jats:sec>\n<jats:title>Background:<\/jats:title>\n<jats:p> Infection, tissue damage and aging can cause inflammation with high levels of inflammatory\ncytokines. Overproduction of inflammatory cytokines often leads to systemic inflammatory response\nsyndrome (SIRS), severe sepsis, and septic shock. However, prominent therapeutic targets have not been found,\nalthough the incidence of sepsis is likely to increase annually. Our recent studies indicate that some RNA-binding\nproteins, which control gene expression of inflammatory cytokines at the post-transcriptional level, may play a\ncritical role in inflammatory diseases such as sepsis.\n<\/jats:p><\/jats:sec>\n<jats:sec>\n<jats:title>Results:<\/jats:title>\n<jats:p> 1) One of the RNA-binding proteins, AT-rich interactive domain-containing 5a (Arid5a) promotes cytokine\nproduction through control of mRNA half-lives of pro-inflammatory molecules such as IL-6, STAT3, T-bet,\nand OX40 in activated macrophages and T cells. Arid5a KO mice are refractory to endotoxin shock, bleomycininduced\nlung injury, and inflammatory autoimmune disease. 2) Chlorpromazine (CPZ), which is recognized as a\npsychotic drug, impairs post-transcriptional gene expression of Il6 in LPS-stimulated macrophages: CPZ inhibits\nthe binding activity of Arid5a to the 3\u2019UTR of Il6 mRNA, thereby destabilizing Il6 mRNA possibly through\nsuppression of Arid5a expression. 3) CPZ has strong suppressive effects on cytokine production such as TNF-\u03b1 in\nvivo. Mice with treatment of CPZ are resistant to lipopolysaccharide (LPS)-induced shock.\n<\/jats:p><\/jats:sec>\n<jats:sec>\n<jats:title>Conclusion:<\/jats:title>\n<jats:p> Thus, Arid5a contributes to the activation of macrophages and T cells through positive control of\nmRNA half-lives of inflammatory cytokines and its related molecules, which might lead to cytokine storm. Interestingly,\nArid5a was identified from an inhibitory effect of CPZ on IL-6 production in macrophages activated by\nLPS. Therefore, CPZ derivatives or Arid5a inhibitors may have a potential to suppress severe sepsis through\ncontrol of post-transcriptional gene expression.<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/1381612824666180426103753","type":"journal-article","created":{"date-parts":[[2018,4,27]],"date-time":"2018-04-27T11:08:04Z","timestamp":1524827284000},"page":"1766-1771","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["A Potential Therapeutic Target RNA-binding Protein, Arid5a for the Treatment of Inflammatory Disease Associated with Aberrant Cytokine Expression"],"prefix":"10.2174","volume":"24","author":[{"given":"Kazuya","family":"Masuda","sequence":"first","affiliation":[{"name":"Howard Hughes Medical Institute, Department of Biochemistry and Biophysics, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania, 19104, United States"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tadamitsu","family":"Kishimoto","sequence":"additional","affiliation":[{"name":"Immune Regulation Laboratory, Immunology Frontier Research Center (IFReC), Osaka University, Osaka, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"965","container-title":["Current Pharmaceutical Design"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/eurekaselect.com\/article\/download\/161575","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/161575\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/eurekaselect.com\/article\/download\/161575","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,12,25]],"date-time":"2020-12-25T19:49:50Z","timestamp":1608925790000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/161575\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8,29]]},"references-count":0,"journal-issue":{"issue":"16","published-print":{"date-parts":[[2018,8,29]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1381612824666180426103753","relation":{},"ISSN":["1381-6128"],"issn-type":[{"value":"1381-6128","type":"print"}],"subject":[],"published":{"date-parts":[[2018,8,29]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2018-01-31","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-04-14","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-04-17","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-08-29","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}